Staphylococcus aureus is a commensal bacterium that usually colonizes the skin and mucous membranes and causes a wide variety of diseases, including soft-tissue and bloodstream infections and life-threatening sepsis (
1,
2). Peptidoglycan biosynthesis in the cell wall of Gram-positive bacteria starts with membrane-bound enzymes called penicillin-binding proteins (e.g., PBP2). Due to the acquisition of
mecA in certain strains, a new protein called PBP2a is encoded. This protein cannot attach to beta-lactam antibiotics, although it retains the enzymatic activity; thus, these strains are called methicillin-resistant
S. aureus (MRSA) (
3).
In recent years, the frequency of MRSA has increased to 60% of the clinical isolates of
S. aureus (
4,
5). Some clinical
mecA and PBP2 positive strains of
S. aureus exhibit phenotypic susceptibility to oxacillin. It has been suggested that such isolates can be classified as a new group of MRSA called oxacillin-susceptible methicillin-resistant
S. aureus (OS-MRSA). They may be incorrectly classified as methicillin-sensitive
S. aureus (MSSA) just because they show phenotypic susceptibility to oxacillin (
6,
7). It is estimated that the prevalence of MRSA and the mortality rate of
S. aureus bacteremia in many countries have raised to more than 49% and 50%, respectively (
8,
9). Recently, the epidemiology of MRSA has changed, and several nosocomial strains have produced community-acquired infections, named community-onset hospital-acquired infections (CO-HA MRSA), or vice versa (HO-CA MRSA) (
10,
11).
The
mecA gene is carried by the cassette chromosome
mecA (SCCmec). Eleven
mecA cassettes (SCCmec) are recognized as
S. aureus (
12,
13). The majority of the prevalent MRSA strains in the community are
SCCmec type IV, while types I, II, and III are associated with hospital-acquired MRSA infections (
5,
14). The routine detection methods of MRSA, like culture and PCR, have several strengths and weaknesses. The disadvantages of these techniques include the high cost of the instruments, and more importantly, the inability to apply as a point of care test (
15,
16). Thus, the development of a low-cost and fast method with high sensitivity and specificity is of utmost importance (
17,
18).
As an alternative method for the diagnosis of MRSA, loop-mediated isothermal amplification (LAMP) was developed by Notomi et al. (
19) in 2000. This method uses the
Bst DNA polymerase that has the ability of strand displacement and yields large fragments of DNA by the auto-cycling reaction. In addition, the LAMP reaction is performed at 60°C - 65°C and is carried out for 60 to 90 min (
20,
21). This method involves six primers especially designed to recognize a total of six distinct sequences on the target DNA. The LAMP method has been used to identify many bacteria, such as
Helicobacter pylori and
Arcobacter, and many parasites, fungi, and viruses (
1,
6,
21,
22).